RE:RE:RE:RE:RE:Total sales of $3,197,000 for the first quarter of 2019 Again, not addressing what was said. If management already wrote-off millions of tax loss balances as not having any value, an additional small amount of CCA on the new plant isn't going to help a company. Especially one which
isn't paying taxes. Thus no future tax asset set up for this "tax shield".
digitel wrote: "The company is not paying taxes, there is no "tax shield"." The company is targeting a functional drink deal by the end of the year and has talked about an upfront payment. "We also remain very active in business development activities for out-licensing of Ceapros products candidates and applications arising from the use of our PGX game-changing technology. Today's news release CZO is VERY active concerning licensing product candidates in the plural and applications of PGX in the plural. There could be more than just an upfront payment for the functional drink and the markets CZO is targeting are sizable. As CZO recently noted in a news release PGX could bring "tremendous" value in "many" ways.